French SL - Search Results

1

Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.

French SL, Arthur JF, Lee H, Nesbitt WS, Andrews RK, Gardiner EE, Hamilton JR. French SL, et al. J Thromb Haemost. 2016 Aug;14(8):1642-54. doi: 10.1111/jth.13293. Epub 2016 Jun 22. J Thromb Haemost. 2016. PMID: 26878340 Free article.

2

Differential signaling by protease-activated receptors: implications for therapeutic targeting.

Sidhu TS, French SL, Hamilton JR. Sidhu TS, et al. Among authors: french sl. Int J Mol Sci. 2014 Apr 11;15(4):6169-83. doi: 10.3390/ijms15046169. Int J Mol Sci. 2014. PMID: 24733067 Free PMC article. Review.

3

Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent.

French SL, Arthur JF, Tran HA, Hamilton JR. French SL, et al. Blood Rev. 2015 May;29(3):179-89. doi: 10.1016/j.blre.2014.10.006. Epub 2014 Nov 6. Blood Rev. 2015. PMID: 25467961 Review.

4

Protease-activated receptor 4: from structure to function and back again.

French SL, Hamilton JR. French SL, et al. Br J Pharmacol. 2016 Oct;173(20):2952-65. doi: 10.1111/bph.13455. Epub 2016 Mar 10. Br J Pharmacol. 2016. PMID: 26844674 Free PMC article. Review.

5

Perinatal lethality of Par4^-/- mice delivered by primiparous dams reveals spontaneous bleeding in mice without platelet thrombin receptor function.

French SL, Hamilton JR. French SL, et al. Platelets. 2018 Mar;29(2):196-198. doi: 10.1080/09537104.2017.1349310. Epub 2017 Sep 29. Platelets. 2018. PMID: 28960148 Free article.

6

The mode of anesthesia influences outcome in mouse models of arterial thrombosis.

Sashindranath M, Sturgeon SA, French S, Craenmehr DDD, Selan C, Freddi S, Johnson C, Cody SH, Nesbitt WS, Hamilton JR, Nandurkar HH. Sashindranath M, et al. Res Pract Thromb Haemost. 2019 Feb 15;3(2):197-206. doi: 10.1002/rth2.12184. eCollection 2019 Apr. Res Pract Thromb Haemost. 2019. PMID: 31011704 Free PMC article.

7

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets.

French SL, Paramitha AC, Moon MJ, Dickins RA, Hamilton JR. French SL, et al. PLoS One. 2016 Oct 27;11(10):e0165565. doi: 10.1371/journal.pone.0165565. eCollection 2016. PLoS One. 2016. PMID: 27788223 Free PMC article.

8

Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window.

French SL, Hamilton JR. French SL, et al. Ann Transl Med. 2017 Dec;5(23):464. doi: 10.21037/atm.2017.09.10. Ann Transl Med. 2017. PMID: 29285497 Free PMC article. No abstract available.

9

A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant.

French SL, Thalmann C, Bray PF, Macdonald LE, Murphy AJ, Sleeman MW, Hamilton JR. French SL, et al. Blood Adv. 2018 Jun 12;2(11):1283-1293. doi: 10.1182/bloodadvances.2017015552. Blood Adv. 2018. PMID: 29884748 Free PMC article.

10

Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902.

Li S, Tarlac V, Christanto RBI, French SL, Hamilton JR. Li S, et al. Among authors: french sl. Platelets. 2021 Oct 3;32(7):988-991. doi: 10.1080/09537104.2020.1810654. Epub 2020 Aug 21. Platelets. 2021. PMID: 32819173 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters